Angela Shen

2 weeks ago | chinatalk.media | Angela Shen

In 2011, China’s drug regulator cleared the nation’s first home-grown targeted cancer pill. Fourteen years later, a Chinese bispecific antibody is aiming to knock the world’s top-selling oncology drug off its perch. Those two bookends frame twin contests now running in parallel. One is humanity’s decades-long fight against cancer, a disease that still claims one in six lives worldwide. The other is China’s effort to move from importing medicines to inventing them.

2 weeks ago | open.substack.com | Angela Shen

In 2011, China’s drug regulator cleared the nation’s first home-grown targeted cancer pill. Fourteen years later, a Chinese bispecific antibody is aiming to knock the world’s top-selling oncology drug off its perch. Those two bookends frame twin contests now running in parallel. One is humanity’s decades-long fight against cancer, a disease that still claims one in six lives worldwide. The other is China’s effort to move from importing medicines to inventing them.

3 weeks ago | chinatalk.media | Angela Shen

Once hailed as the “Apple of China,” Xiaomi has evolved into the world’s No. 3 smartphone brand. The Beijing giant wires millions of homes with its TVs, wearables, and appliances while pitching itself as a seamless “Human × Car × Home” platform. Founder Lei Jun now wants to turn that consumer-electronics prowess into hard-tech dominance. In 2025 alone, Xiaomi debuted its first in-house chip (the XRING O1) and showed off its sleek SU7 electric sedan.

1 month ago | chinatalk.media | Angela Shen

Created by the United States Congress in 2022, the National Security Commission on Emerging Biotechnology (NSCEB) is an independent, bipartisan body tasked with assessing biotech’s national security implications. Modeled after the earlier AI Commission, the NSCEB recently released its report of recommendations to ensure the US's future leadership in biotechnology. Their report signals something important: biotech is moving from policy background noise to strategic priority.

2 months ago | chinatalk.media | Angela Shen |Jordan Schneider

Of all the policies Trump has rolled out, the two I’m most worried will have irreversible consequences for long term national power are undermining our alliance structure and the attractiveness of the country for high end international talent. Angela Shen (ChinaTalk’s robotics and biotech analyst) and I published a piece earlier this week in The Washington Post, arguing how America’s student visa system is critical for future science and tech success.